| Target Price | kr35.19 |
| Price | kr20.30 |
| Potential |
73.35%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Genovis 2027 .
The average Genovis target price is kr35.19.
This is
73.35%
register free of charge
kr43.05
112.07%
register free of charge
kr28.28
39.31%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Genovis to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Genovis stock has an average upside potential 2027 of
73.35%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million kr | 128.95 | 155.04 |
| 1.08% | 20.23% | |
| EBITDA Margin | 31.10% | 29.61% |
| 1.63% | 4.78% | |
| Net Margin | 18.22% | 17.75% |
| 27.83% | 2.60% |
3 Analysts have issued a sales forecast Genovis 2026 . The average Genovis sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Genovis EBITDA forecast 2026. The average Genovis EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Genovis Analysts have issued a net profit forecast 2026. The average Genovis net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 0.36 | 0.41 |
| 28.00% | 13.89% | |
| P/E | 49.75 | |
| EV/Sales | 8.12 |
3 Analysts have issued a Genovis forecast for earnings per share. The average Genovis EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


